From: Intrapartum care
Copyright © NICE 2023.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Intrapartum care. London: National Institute for Health and Care Excellence (NICE); 2023 Sep 29. (NICE Clinical Guidelines, No. 235.)
Intrapartum care.
Show detailsTable 8Medical conditions indicating individual assessment is needed when planning place of birth
| Disease area | Medical condition |
|---|---|
| Cardiovascular | Cardiac disease without intrapartum implications |
| Haematological |
|
| Endocrine | Unstable hypothyroidism such that a change in treatment is needed |
| Infective |
|
| Immune | Non-specific connective tissue disorders |
| Skeletal/Neurological |
|
| Gastrointestinal |
|
- NICE Clinical Guidelines 190: Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth
- Evidence reviews for impact of BMI on choice of place of birth: Intrapartum care: Evidence review A
- Evidence reviews for initial assessment of women reporting prelabour rupture of membranes: Intrapartum care: Evidence review B
- Evidence reviews for sterile water injections: Intrapartum care: Evidence review C
- Evidence reviews for remifentanil patient-controlled analgesia: Intrapartum care: Evidence review D
- Evidence reviews for programmed intermittent epidural bolus: Intrapartum care: Evidence review E
- Evidence reviews for use of oxytocin in the first or second stage of labour: Intrapartum care: Evidence review F
- Evidence reviews for position for birth: Intrapartum care: Evidence review G
- Evidence reviews for pushing techniques: Intrapartum care: Evidence review H
- Evidence reviews for interventions to reduce perineal trauma: Intrapartum care: Evidence review I
- Evidence reviews for prophylactic antibiotics for birth with forceps or ventouse: Intrapartum care: Evidence review J
- Evidence reviews for active and physiological management of the third stage: Intrapartum care: Evidence review K
- Evidence reviews for route of administration of oxytocin in the third stage of labour: Intrapartum care: Evidence review L
- Evidence reviews for uterotonics for the prevention of postpartum haemorrhage: Intrapartum care: Evidence review M
- Evidence reviews for position of the baby during cord clamping: Intrapartum care: Evidence review N
- Evidence reviews for pharmacological management of postpartum haemorrhage: Intrapartum care: Evidence review O
- 2023 exceptional surveillance of intrapartum care for healthy women and babies (NICE guideline CG190)
- Review Intrapartum care for healthy women and babies[ 2022]Review Intrapartum care for healthy women and babies. 2022 Dec 14
- No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.[J Obstet Gynaecol Can. 2018]No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras V, Gray C, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, et al. J Obstet Gynaecol Can. 2018 Nov; 40(11):1528-1537. Epub 2018 Oct 5.
- Review Twin and triplet pregnancy[ 2024]Review Twin and triplet pregnancy. 2024 Apr 9
- Review Fetal monitoring in labour[ 2022]Review Fetal monitoring in labour. 2022 Dec 14
- Vaginal delivery of breech presentation.[J Obstet Gynaecol Can. 2009]Vaginal delivery of breech presentation.Kotaska A, Menticoglou S, Gagnon R, MATERNAL FETAL MEDICINE COMMITTEE. J Obstet Gynaecol Can. 2009 Jun; 31(6):557-566.
- Table 8, Medical conditions indicating individual assessment is needed when plan...Table 8, Medical conditions indicating individual assessment is needed when planning place of birth - Intrapartum care
- 393497[uid] (1)Taxonomy
- Homo sapiens acyl-CoA thioesterase 7 (ACOT7), transcript variant hBACHc, mRNAHomo sapiens acyl-CoA thioesterase 7 (ACOT7), transcript variant hBACHc, mRNAgi|1677499564|ref|NM_181865.3|Nucleotide
- Homo sapiens vav 2 guanine nucleotide exchange factor, mRNA (cDNA clone MGC:1645...Homo sapiens vav 2 guanine nucleotide exchange factor, mRNA (cDNA clone MGC:164596 IMAGE:40146987), complete cdsgi|124376645|gb|BC132965.1|Nucleotide
- PREDICTED: Homo sapiens spindlin interactor and repressor of chromatin binding (...PREDICTED: Homo sapiens spindlin interactor and repressor of chromatin binding (SPINDOC), transcript variant X2, mRNAgi|2217281292|ref|XM_006718437.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...